Entity
  • Fusion Antibodies

    Created in 2001
  • BETA

    Up & running (A)
    Existing signals show a regular activity
  • Social networks

    1,196 4,727
  • Activities

  • Technologies

  • Entity types

  • Location

    Springbank Industrial Estate, Pembroke Loop Rd, Belfast BT17 0QL, UK

    BELFAST

    United Kingdom

  • Employees

    Scale: 11-50

    Estimated: 29

  • Engaged corporates

    5
    1 1
  • Added in Motherbase

    6 years, 2 months ago
Description
  • Value proposition

    Antibody Services from Discovery to Clinical Supply

    Since 2001, Fusion Antibodies has been dedicated to the discovery and early development of antibodies to help bring about a positive change in the healthcare industry.
    We offer a complete range of antibody-related services in Discovery, Engineering and Supply and have guided hundreds of projects through critical preclinical stages.
    Fifteen of our client’s projects have advanced to clinical stages, some as far as Phase II.

    We deliver a superior service for the development of antibodies by beginning each project with the end in mind. Our scientists are experts in early stage discovery of biologics.

    We offer this personalised service because we know that investment at the early stages saves not only millions of dollars but also months, even years of time, on projects that go awry at later stages of development.

    Through our vast experience we have developed a number of our own proprietary platforms for Antibody Humanization (CRXTM), Affinity Maturation (RAMPTM) and Developability optimisation (ADDTM).

    Fusion Antibodies is a publicly held company, trading on the London Stock Exchange (LSE FAB.L) with headquarters in Belfast, Northern Ireland.

    Antibody Humanization, Protein Expression & Purification Services, Monoclonal Antibody services BLAST & Standard, Antibody Sequencing Services, InVitro Diagnostic proteins, Antibody Engineering, Cell Line Development, Affinity Maturation Services, and Antibody Developability by Design

  • R&D Antibody Discovery Partner | Fusion Antibodies

    Fusion Antibodies offer a complete end-to-end service from antigen design to cell line development. R&D Antibody Discovery Partner.

  • https://fusionantibodies.com/
Corporate interactions BETA
Corporate TypeTweets Articles
UK Research and Innovation
UK Research and Innovation
Public business cluster, Government Administration
UK Research and Innovation
Public business cluster, Government Administration
Other

25 Jun 2020


Biogen
Biogen
Biotechnology, Biotechnology Research
Biogen
Biotechnology, Biotechnology Research
Other

30 Nov 2022

30 Nov 2022



Bayer
Bayer
Pharmaceutical, Chemistry, Chemical Manufacturing
Bayer
Pharmaceutical, Chemistry, Chemical Manufacturing
Other

20 Jun 2018


London Stock Exchange
London Stock Exchange
Finance, Financial Services
London Stock Exchange
Finance, Financial Services
Not capitalistic
Partnership
Not event

18 Dec 2017


Eurofins Scientifique
Eurofins Scientifique
Biotechnology, Biotechnology Research
Eurofins Scientifique
Biotechnology, Biotechnology Research
Not capitalistic
Partnership
Not event

25 Aug 2021


Similar entities
Loading...
Loading...
Social network dynamics